首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Protein-based alignment in 3D QSAR of 26 indole inhibitors of human pancreatic phospholipase A2.
【24h】

Protein-based alignment in 3D QSAR of 26 indole inhibitors of human pancreatic phospholipase A2.

机译:人胰腺磷脂酶A2的26种吲哚抑制剂在3D QSAR中的基于蛋白质的比对。

获取原文
获取原文并翻译 | 示例
           

摘要

An automated docking procedure was applied on a series of 26 reversible and competitive indole inhibitors of human pancreatic phospholipase A2 (hp-PLA2). X-ray data of this enzyme are not available and the structure was then reconstructed exploiting its protein sequence and the crystallographic data of a bovine pancreatic source. The docking data were used to build a three-dimensional quantitative structure-activity relationship (3D QSAR) model, established using the comparative molecular field analysis (CoMFA) method. This model, joined to the previous one developed for the indole inhibitors of human non-pancreatic secretory phospholipase A2 (hnps-PLA2), an enzyme involved in inflammation processes, will allow for the selection of new strong anti-inflammatory drugs with negligible side effects, at least at the level of hp-PLA2.
机译:将自动对接程序应用于一系列26种可逆和竞争性的人胰磷脂酶A2(hp-PLA2)吲哚抑制剂。无法获得该酶的X射线数据,然后利用其蛋白质序列和牛胰腺来源的晶体学数据重建结构。利用对接数据建立了三维定量构效关系(3D QSAR)模型,该模型是使用比较分子场分析(CoMFA)方法建立的。该模型与先前开发的用于人类非胰腺分泌型磷脂酶A2(hnps-PLA2)的吲哚抑制剂的模型相结合,该酶是一种参与炎症过程的酶,将有助于选择副作用可忽略不计的新型强抗炎药,至少达到hp-PLA2的水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号